1-(4-chlorobenzyl)piperidin-4-ol
- $450 - $1238
- Product name: 1-(4-chlorobenzyl)piperidin-4-ol
- CAS: 21937-62-2
- MF: C12H16ClNO
- MW: 225.71
- EINECS:
- MDL Number:MFCD00976663
- Synonyms:1-(4-chlorobenzyl)piperidin-4-ol;4-Piperidinol, 1-[(4-chlorophenyl)methyl]-
5 prices
Selected condition:
Brand
- A1 Biochem Labs
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 5MG
- 1g
- 5g
- ManufacturerA1 Biochem Labs
- Product number6572600
- Product description1-(4-Chloro-benzyl)-piperidin-4-ol 95%
- Packaging1g
- Price$450
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0123823
- Product description1-(4-CHLORO-BENZYL)-PIPERIDIN-4-OL 95.00%
- Packaging5MG
- Price$496.2
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11164555
- Product description1-(4-Chlorobenzyl)piperidin-4-ol 95+%
- Packaging1g
- Price$455
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number183579
- Product description1-(4-Chlorobenzyl)-piperidin-4-ol 95%
- Packaging1g
- Price$578
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number183579
- Product description1-(4-Chlorobenzyl)-piperidin-4-ol 95%
- Packaging5g
- Price$1238
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
A1 Biochem Labs | 6572600 | 1-(4-Chloro-benzyl)-piperidin-4-ol 95% | 1g | $450 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0123823 | 1-(4-CHLORO-BENZYL)-PIPERIDIN-4-OL 95.00% | 5MG | $496.2 | 2021-12-16 | Buy |
Crysdot | CD11164555 | 1-(4-Chlorobenzyl)piperidin-4-ol 95+% | 1g | $455 | 2021-12-16 | Buy |
Matrix Scientific | 183579 | 1-(4-Chlorobenzyl)-piperidin-4-ol 95% | 1g | $578 | 2021-12-16 | Buy |
Matrix Scientific | 183579 | 1-(4-Chlorobenzyl)-piperidin-4-ol 95% | 5g | $1238 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|